2023-2029 Global CD31 Antibody Industry Research & Trends Analysis Report
According to the Latest Research Report,, the global market for CD31 Antibody should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
Growing patient base, launch of novel CD31 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in CD31 antibody market revenue.
CD31 Antibody can be used in a variety of scientific applications, including western blotting, immunohistochemistry, immunocytochemistry, immunoprecipitation, and ELISA. These antibodies target CD31 in human, mouse, rat, rabbit and pig samples.
This report aims to provide a comprehensive study of the global market for CD31 Antibody.
Key Highlights of the Report
(1) Global CD31 Antibody market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global CD31 Antibody market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China CD31 Antibody market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global CD31 Antibody segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global CD31 Antibody segment by type and by application and regional segment by type and by application.
(6) Global major production regions of CD31 Antibody, capacity, production and trends.
(7) CD31 Antibody industry supply chain, upstream, midstream and downstream analysis.
Key Regions Covered in This Report Are:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Monoclonal
Polyclonal
Market segment by application, can be divided into
Immunochemistry (IHC)
Immunofluorescence (IF)
Western Blot (WB)
Immunocytochemistry (ICC)
ELISA
Others
Market segment by players, this report covers
BosterBio
Bio-Rad
Bioss
Thermo Fisher Scientific
NSJ Bioreagents
R and D Systems
Abcam
BioLegend
GeneTex
Novus Biologicals
SouthernBiotech
LifeSpan BioSciences
Enzo Life Sciences
Bethyl Laboratories
Abbexa
ProSci
Proteintech
Synaptic Systems
BIOCARE MEDICAL
CUSABIO Technology
Absolute Antibody
EpiGentek
Biorbyt
Wuhan Fine Biotech
Sino Biological
1 Market Overview
1.1 CD31 Antibody Definition
1.2 Global CD31 Antibody Market Size and Forecast
1.2.1 By Revenue, Global CD31 Antibody Market Size, 2018-2029
1.2.2 By Sales Volume, Global CD31 Antibody Market Size, 2018-2029
1.2.3 Global CD31 Antibody Price Trend, 2018-2029
1.3 China CD31 Antibody Market Size and Forecast
1.3.1 By Revenue, China CD31 Antibody Market Size, 2018-2029
1.3.2 By Sales Volume, China CD31 Antibody Market Size, 2018-2029
1.3.3 China CD31 Antibody Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China CD31 Antibody Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China CD31 Antibody Share in Global Market, 2018-2029
1.4.3 CD31 Antibody Market Size: China VS Global, 2018-2029
1.5 CD31 Antibody Market Dynamics
1.5.1 CD31 Antibody Market Drivers
1.5.2 CD31 Antibody Market Restraints
1.5.3 CD31 Antibody Industry Trends
1.5.4 CD31 Antibody Industry Policy
2 Global Competitive Landscape by Company
2.1 Global CD31 Antibody Revenue by Company, 2018-2023
2.2 Global CD31 Antibody Sales Volume by Company, 2018-2023
2.3 Global CD31 Antibody Price by Company, 2018-2023
2.4 Global CD31 Antibody Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global CD31 Antibody Concentration Ratio
2.6 Global CD31 Antibody Mergers & Acquisitions, Expansion Plans
2.7 Global CD31 Antibody Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China CD31 Antibody Revenue by Company, 2018-2023
3.2 China CD31 Antibody Sales Volume by Company, 2018-2023
3.3 China CD31 Antibody CD31 Antibody Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China CD31 Antibody Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, CD31 Antibody Domestic VS Export
3.6 China Market, CD31 Antibody Import & Export
3.6.1 China Market, CD31 Antibody Import & Export, 2018-2029
3.6.2 China CD31 Antibody Import & Export Trends
3.6.3 Main Sources of China CD31 Antibody Import
3.6.4 Export Destination of China CD31 Antibody
4 CD31 Antibody Production by Region
4.1 Global CD31 Antibody Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of CD31 Antibody Manufacturers
4.3 Global Major Manufacturers, CD31 Antibody Capacity Expansion and Future Plans
4.4 Global CD31 Antibody Capacity by Region
4.5 Global CD31 Antibody Production by Region
4.5.1 Global CD31 Antibody Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global CD31 Antibody Production by Region, 2018-2023
4.5.3 Global CD31 Antibody Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 CD31 Antibody Industry Chain
5.2 CD31 Antibody Upstream Analysis
5.2.1 CD31 Antibody Core Raw Materials
5.2.2 Main Manufacturers of CD31 Antibody Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 CD31 Antibody Production Mode
5.6 CD31 Antibody Procurement Model
5.7 CD31 Antibody Industry Sales Model and Sales Channels
5.7.1 CD31 Antibody Sales Model
5.7.2 CD31 Antibody Typical Distributors
6 Sights by Type
6.1 CD31 Antibody Classification
6.1.1 Monoclonal
6.1.2 Polyclonal
6.2 By Type, Global CD31 Antibody Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global CD31 Antibody Revenue, 2018-2029
6.4 By Type, Global CD31 Antibody Sales Volume, 2018-2029
6.5 By Type, Global CD31 Antibody Price, 2018-2029
7 Sights by Application
7.1 CD31 Antibody Segment by Application
7.1.1 Immunochemistry (IHC)
7.1.2 Immunofluorescence (IF)
7.1.3 Western Blot (WB)
7.1.4 Immunocytochemistry (ICC)
7.1.5 ELISA
7.1.6 Others
7.2 By Application, Global CD31 Antibody Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global CD31 Antibody Revenue, 2018-2029
7.4 By Application, Global CD31 Antibody Sales Volume, 2018-2029
7.5 By Application, Global CD31 Antibody Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global CD31 Antibody Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global CD31 Antibody Revenue, 2018-2029
8.3 By Region, Global CD31 Antibody Sales Volume, 2018-2029
8.4 North America
8.4.1 North America CD31 Antibody Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America CD31 Antibody Market Size Market Share
8.5 Europe
8.5.1 Europe CD31 Antibody Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe CD31 Antibody Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific CD31 Antibody Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific CD31 Antibody Market Size Market Share
8.7 South America
8.7.1 South America CD31 Antibody Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America CD31 Antibody Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global CD31 Antibody Market Size & CAGR，2018 VS 2022 VS 2029
9.2 By Country, Global CD31 Antibody Revenue, 2018-2029
9.3 By Country, Global CD31 Antibody Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. CD31 Antibody Market Size, 2018-2029
9.4.2 By Company, U.S. CD31 Antibody Sales Volume Market Share, 2022
9.4.3 By Type, U.S. CD31 Antibody Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. CD31 Antibody Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe CD31 Antibody Market Size, 2018-2029
9.5.2 By Company, Europe CD31 Antibody Sales Volume Market Share, 2022
9.5.3 By Type, Europe CD31 Antibody Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe CD31 Antibody Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China CD31 Antibody Market Size, 2018-2029
9.6.2 By Company, China CD31 Antibody Sales Volume Market Share, 2022
9.6.3 By Type, China CD31 Antibody Market Size, Share, 2022 VS 2029
9.6.4 By Application, China CD31 Antibody Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan CD31 Antibody Market Size, 2018-2029
9.7.2 By Company, Japan CD31 Antibody Sales Volume Market Share, 2022
9.7.3 By Type, Japan CD31 Antibody Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan CD31 Antibody Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea CD31 Antibody Market Size, 2018-2029
9.8.2 By Company, South Korea CD31 Antibody Sales Volume Market Share, 2022
9.8.3 By Type, South Korea CD31 Antibody Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea CD31 Antibody Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia CD31 Antibody Market Size, 2018-2029
9.9.2 By Company, Southeast Asia CD31 Antibody Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia CD31 Antibody Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia CD31 Antibody Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India CD31 Antibody Market Size, 2018-2029
9.10.2 By Company, India CD31 Antibody Sales Volume Market Share, 2022
9.10.3 By Type, India CD31 Antibody Market Size, Share, 2022 VS 2029
9.10.4 By Application, India CD31 Antibody Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia CD31 Antibody Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia CD31 Antibody Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia CD31 Antibody Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia CD31 Antibody Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 BosterBio
10.1.1 BosterBio Company Information, Head Office, Market Area and Industry Position
10.1.2 BosterBio CD31 Antibody Models, Specifications and Application
10.1.3 BosterBio CD31 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 BosterBio Company Profile and Main Business
10.1.5 BosterBio Recent Developments
10.2 Bio-Rad
10.2.1 Bio-Rad Company Information, Head Office, Market Area and Industry Position
10.2.2 Bio-Rad CD31 Antibody Models, Specifications and Application
10.2.3 Bio-Rad CD31 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Bio-Rad Company Profile and Main Business
10.2.5 Bio-Rad Recent Developments
10.3 Bioss
10.3.1 Bioss Company Information, Head Office, Market Area and Industry Position
10.3.2 Bioss CD31 Antibody Models, Specifications and Application
10.3.3 Bioss CD31 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Bioss Company Profile and Main Business
10.3.5 Bioss Recent Developments
10.4 Thermo Fisher Scientific
10.4.1 Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position
10.4.2 Thermo Fisher Scientific CD31 Antibody Models, Specifications and Application
10.4.3 Thermo Fisher Scientific CD31 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Thermo Fisher Scientific Company Profile and Main Business
10.4.5 Thermo Fisher Scientific Recent Developments
10.5 NSJ Bioreagents
10.5.1 NSJ Bioreagents Company Information, Head Office, Market Area and Industry Position
10.5.2 NSJ Bioreagents CD31 Antibody Models, Specifications and Application
10.5.3 NSJ Bioreagents CD31 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 NSJ Bioreagents Company Profile and Main Business
10.5.5 NSJ Bioreagents Recent Developments
10.6 R and D Systems
10.6.1 R and D Systems Company Information, Head Office, Market Area and Industry Position
10.6.2 R and D Systems CD31 Antibody Models, Specifications and Application
10.6.3 R and D Systems CD31 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 R and D Systems Company Profile and Main Business
10.6.5 R and D Systems Recent Developments
10.7 Abcam
10.7.1 Abcam Company Information, Head Office, Market Area and Industry Position
10.7.2 Abcam CD31 Antibody Models, Specifications and Application
10.7.3 Abcam CD31 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Abcam Company Profile and Main Business
10.7.5 Abcam Recent Developments
10.8 BioLegend
10.8.1 BioLegend Company Information, Head Office, Market Area and Industry Position
10.8.2 BioLegend CD31 Antibody Models, Specifications and Application
10.8.3 BioLegend CD31 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 BioLegend Company Profile and Main Business
10.8.5 BioLegend Recent Developments
10.9 GeneTex
10.9.1 GeneTex Company Information, Head Office, Market Area and Industry Position
10.9.2 GeneTex CD31 Antibody Models, Specifications and Application
10.9.3 GeneTex CD31 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 GeneTex Company Profile and Main Business
10.9.5 GeneTex Recent Developments
10.10 Novus Biologicals
10.10.1 Novus Biologicals Company Information, Head Office, Market Area and Industry Position
10.10.2 Novus Biologicals CD31 Antibody Models, Specifications and Application
10.10.3 Novus Biologicals CD31 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Novus Biologicals Company Profile and Main Business
10.10.5 Novus Biologicals Recent Developments
10.11 SouthernBiotech
10.11.1 SouthernBiotech Company Information, Head Office, Market Area and Industry Position
10.11.2 SouthernBiotech CD31 Antibody Models, Specifications and Application
10.11.3 SouthernBiotech CD31 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 SouthernBiotech Company Profile and Main Business
10.11.5 SouthernBiotech Recent Developments
10.12 LifeSpan BioSciences
10.12.1 LifeSpan BioSciences Company Information, Head Office, Market Area and Industry Position
10.12.2 LifeSpan BioSciences CD31 Antibody Models, Specifications and Application
10.12.3 LifeSpan BioSciences CD31 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 LifeSpan BioSciences Company Profile and Main Business
10.12.5 LifeSpan BioSciences Recent Developments
10.13 Enzo Life Sciences
10.13.1 Enzo Life Sciences Company Information, Head Office, Market Area and Industry Position
10.13.2 Enzo Life Sciences CD31 Antibody Models, Specifications and Application
10.13.3 Enzo Life Sciences CD31 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Enzo Life Sciences Company Profile and Main Business
10.13.5 Enzo Life Sciences Recent Developments
10.14 Bethyl Laboratories
10.14.1 Bethyl Laboratories Company Information, Head Office, Market Area and Industry Position
10.14.2 Bethyl Laboratories CD31 Antibody Models, Specifications and Application
10.14.3 Bethyl Laboratories CD31 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Bethyl Laboratories Company Profile and Main Business
10.14.5 Bethyl Laboratories Recent Developments
10.15 Abbexa
10.15.1 Abbexa Company Information, Head Office, Market Area and Industry Position
10.15.2 Abbexa CD31 Antibody Models, Specifications and Application
10.15.3 Abbexa CD31 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Abbexa Company Profile and Main Business
10.15.5 Abbexa Recent Developments
10.16 ProSci
10.16.1 ProSci Company Information, Head Office, Market Area and Industry Position
10.16.2 ProSci CD31 Antibody Models, Specifications and Application
10.16.3 ProSci CD31 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.16.4 ProSci Company Profile and Main Business
10.16.5 ProSci Recent Developments
10.17 Proteintech
10.17.1 Proteintech Company Information, Head Office, Market Area and Industry Position
10.17.2 Proteintech CD31 Antibody Models, Specifications and Application
10.17.3 Proteintech CD31 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.17.4 Proteintech Company Profile and Main Business
10.17.5 Proteintech Recent Developments
10.18 Synaptic Systems
10.18.1 Synaptic Systems Company Information, Head Office, Market Area and Industry Position
10.18.2 Synaptic Systems CD31 Antibody Models, Specifications and Application
10.18.3 Synaptic Systems CD31 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.18.4 Synaptic Systems Company Profile and Main Business
10.18.5 Synaptic Systems Recent Developments
10.19 BIOCARE MEDICAL
10.19.1 BIOCARE MEDICAL Company Information, Head Office, Market Area and Industry Position
10.19.2 BIOCARE MEDICAL CD31 Antibody Models, Specifications and Application
10.19.3 BIOCARE MEDICAL CD31 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.19.4 BIOCARE MEDICAL Company Profile and Main Business
10.19.5 BIOCARE MEDICAL Recent Developments
10.20 CUSABIO Technology
10.20.1 CUSABIO Technology Company Information, Head Office, Market Area and Industry Position
10.20.2 CUSABIO Technology CD31 Antibody Models, Specifications and Application
10.20.3 CUSABIO Technology CD31 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.20.4 CUSABIO Technology Company Profile and Main Business
10.20.5 CUSABIO Technology Recent Developments
10.21 Absolute Antibody
10.21.1 Absolute Antibody Company Information, Head Office, Market Area and Industry Position
10.21.2 Absolute Antibody CD31 Antibody Models, Specifications and Application
10.21.3 Absolute Antibody CD31 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.21.4 Absolute Antibody Company Profile and Main Business
10.21.5 Absolute Antibody Recent Developments
10.22 EpiGentek
10.22.1 EpiGentek Company Information, Head Office, Market Area and Industry Position
10.22.2 EpiGentek CD31 Antibody Models, Specifications and Application
10.22.3 EpiGentek CD31 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.22.4 EpiGentek Company Profile and Main Business
10.22.5 EpiGentek Recent Developments
10.23 Biorbyt
10.23.1 Biorbyt Company Information, Head Office, Market Area and Industry Position
10.23.2 Biorbyt CD31 Antibody Models, Specifications and Application
10.23.3 Biorbyt CD31 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.23.4 Biorbyt Company Profile and Main Business
10.23.5 Biorbyt Recent Developments
10.24 Wuhan Fine Biotech
10.24.1 Wuhan Fine Biotech Company Information, Head Office, Market Area and Industry Position
10.24.2 Wuhan Fine Biotech CD31 Antibody Models, Specifications and Application
10.24.3 Wuhan Fine Biotech CD31 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.24.4 Wuhan Fine Biotech Company Profile and Main Business
10.24.5 Wuhan Fine Biotech Recent Developments
10.25 Sino Biological
10.25.1 Sino Biological Company Information, Head Office, Market Area and Industry Position
10.25.2 Sino Biological CD31 Antibody Models, Specifications and Application
10.25.3 Sino Biological CD31 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.25.4 Sino Biological Company Profile and Main Business
10.25.5 Sino Biological Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. CD31 Antibody Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. CD31 Antibody Market Restraints
Table 3. CD31 Antibody Market Trends
Table 4. CD31 Antibody Industry Policy
Table 5. Global CD31 Antibody Revenue by Company, 2018-2023, US$ million
Table 6. Global CD31 Antibody Revenue Market Share by Company, 2018-2023
Table 7. Global CD31 Antibody Sales Volume by Company, 2018-2023, (L)
Table 8. Global CD31 Antibody Sales Volume Market Share by Company, 2018-2023
Table 9. Global CD31 Antibody Price by Company, 2018-2023, (US$/L)
Table 10. Global CD31 Antibody Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global CD31 Antibody Mergers & Acquisitions, Expansion Plans
Table 12. Global CD31 Antibody Manufacturers Product Type
Table 13. China CD31 Antibody Revenue by Company, 2018-2023, US$ million
Table 14. China CD31 Antibody Revenue Market Share by Company, 2018-2023
Table 15. China CD31 Antibody Sales Volume by Company, 2018-2023, (L)
Table 16. China CD31 Antibody Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, CD31 Antibody Production, Sales, Import and Export, 2018-2029, (L)
Table 18. China CD31 Antibody Import & Export Trends
Table 19. Main Sources of China CD31 Antibody Import
Table 20. Export Destination of China CD31 Antibody
Table 21. Global Headquarters and Manufacturing Base of CD31 Antibody Manufacturers
Table 22. Global Major Manufacturers, CD31 Antibody Capacity Expansion and Future Plans
Table 23. Global CD31 Antibody Production & Forecast by Region, 2018 VS 2022 VS 2029, (L)
Table 24. Global CD31 Antibody Production by Region, 2018-2023, (L)
Table 25. Global CD31 Antibody Production Forecast by Region, 2023-2029, (L)
Table 26. Global Key Players of CD31 Antibody Upstream (Raw Materials)
Table 27. Global CD31 Antibody Typical Customers
Table 28. CD31 Antibody Typical Distributors
Table 29. By Type, Global CD31 Antibody Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global CD31 Antibody Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global CD31 Antibody Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global CD31 Antibody Revenue, 2018-2029, US$ Million
Table 33. By Region, Global CD31 Antibody Sales Volume, 2018-2029, (L)
Table 34. By Country, Global CD31 Antibody Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global CD31 Antibody Revenue, 2018-2029, US$ Million
Table 36. By Country, Global CD31 Antibody Revenue Market Share, 2018-2029
Table 37. By Country, Global CD31 Antibody Sales Volume, 2018-2029, (L)
Table 38. By Country, Global CD31 Antibody Sales Volume Market Share, 2018-2029
Table 39. BosterBio Company Information, Head Office, Market Area and Industry Position
Table 40. BosterBio CD31 Antibody Models, Specifications and Application
Table 41. BosterBio CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 42. BosterBio Company Profile and Main Business
Table 43. BosterBio Recent Developments
Table 44. Bio-Rad Company Information, Head Office, Market Area and Industry Position
Table 45. Bio-Rad CD31 Antibody Models, Specifications and Application
Table 46. Bio-Rad CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 47. Bio-Rad Company Profile and Main Business
Table 48. Bio-Rad Recent Developments
Table 49. Bioss Company Information, Head Office, Market Area and Industry Position
Table 50. Bioss CD31 Antibody Models, Specifications and Application
Table 51. Bioss CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 52. Bioss Company Profile and Main Business
Table 53. Bioss Recent Developments
Table 54. Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position
Table 55. Thermo Fisher Scientific CD31 Antibody Models, Specifications and Application
Table 56. Thermo Fisher Scientific CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 57. Thermo Fisher Scientific Company Profile and Main Business
Table 58. Thermo Fisher Scientific Recent Developments
Table 59. NSJ Bioreagents Company Information, Head Office, Market Area and Industry Position
Table 60. NSJ Bioreagents CD31 Antibody Models, Specifications and Application
Table 61. NSJ Bioreagents CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 62. NSJ Bioreagents Company Profile and Main Business
Table 63. NSJ Bioreagents Recent Developments
Table 64. R and D Systems Company Information, Head Office, Market Area and Industry Position
Table 65. R and D Systems CD31 Antibody Models, Specifications and Application
Table 66. R and D Systems CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 67. R and D Systems Company Profile and Main Business
Table 68. R and D Systems Recent Developments
Table 69. Abcam Company Information, Head Office, Market Area and Industry Position
Table 70. Abcam CD31 Antibody Models, Specifications and Application
Table 71. Abcam CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 72. Abcam Company Profile and Main Business
Table 73. Abcam Recent Developments
Table 74. BioLegend Company Information, Head Office, Market Area and Industry Position
Table 75. BioLegend CD31 Antibody Models, Specifications and Application
Table 76. BioLegend CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 77. BioLegend Company Profile and Main Business
Table 78. BioLegend Recent Developments
Table 79. GeneTex Company Information, Head Office, Market Area and Industry Position
Table 80. GeneTex CD31 Antibody Models, Specifications and Application
Table 81. GeneTex CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 82. GeneTex Company Profile and Main Business
Table 83. GeneTex Recent Developments
Table 84. Novus Biologicals Company Information, Head Office, Market Area and Industry Position
Table 85. Novus Biologicals CD31 Antibody Models, Specifications and Application
Table 86. Novus Biologicals CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 87. Novus Biologicals Company Profile and Main Business
Table 88. Novus Biologicals Recent Developments
Table 89. SouthernBiotech Company Information, Head Office, Market Area and Industry Position
Table 90. SouthernBiotech CD31 Antibody Models, Specifications and Application
Table 91. SouthernBiotech CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 92. SouthernBiotech Company Profile and Main Business
Table 93. SouthernBiotech Recent Developments
Table 94. LifeSpan BioSciences Company Information, Head Office, Market Area and Industry Position
Table 95. LifeSpan BioSciences CD31 Antibody Models, Specifications and Application
Table 96. LifeSpan BioSciences CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 97. LifeSpan BioSciences Company Profile and Main Business
Table 98. LifeSpan BioSciences Recent Developments
Table 99. Enzo Life Sciences Company Information, Head Office, Market Area and Industry Position
Table 100. Enzo Life Sciences CD31 Antibody Models, Specifications and Application
Table 101. Enzo Life Sciences CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 102. Enzo Life Sciences Company Profile and Main Business
Table 103. Enzo Life Sciences Recent Developments
Table 104. Bethyl Laboratories Company Information, Head Office, Market Area and Industry Position
Table 105. Bethyl Laboratories CD31 Antibody Models, Specifications and Application
Table 106. Bethyl Laboratories CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 107. Bethyl Laboratories Company Profile and Main Business
Table 108. Bethyl Laboratories Recent Developments
Table 109. Abbexa Company Information, Head Office, Market Area and Industry Position
Table 110. Abbexa CD31 Antibody Models, Specifications and Application
Table 111. Abbexa CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 112. Abbexa Company Profile and Main Business
Table 113. Abbexa Recent Developments
Table 114. ProSci Company Information, Head Office, Market Area and Industry Position
Table 115. ProSci CD31 Antibody Models, Specifications and Application
Table 116. ProSci CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 117. ProSci Company Profile and Main Business
Table 118. ProSci Recent Developments
Table 119. Proteintech Company Information, Head Office, Market Area and Industry Position
Table 120. Proteintech CD31 Antibody Models, Specifications and Application
Table 121. Proteintech CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 122. Proteintech Company Profile and Main Business
Table 123. Proteintech Recent Developments
Table 124. Synaptic Systems Company Information, Head Office, Market Area and Industry Position
Table 125. Synaptic Systems CD31 Antibody Models, Specifications and Application
Table 126. Synaptic Systems CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 127. Synaptic Systems Company Profile and Main Business
Table 128. Synaptic Systems Recent Developments
Table 129. BIOCARE MEDICAL Company Information, Head Office, Market Area and Industry Position
Table 130. BIOCARE MEDICAL CD31 Antibody Models, Specifications and Application
Table 131. BIOCARE MEDICAL CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 132. BIOCARE MEDICAL Company Profile and Main Business
Table 133. BIOCARE MEDICAL Recent Developments
Table 134. CUSABIO Technology Company Information, Head Office, Market Area and Industry Position
Table 135. CUSABIO Technology CD31 Antibody Models, Specifications and Application
Table 136. CUSABIO Technology CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 137. CUSABIO Technology Company Profile and Main Business
Table 138. CUSABIO Technology Recent Developments
Table 139. Absolute Antibody Company Information, Head Office, Market Area and Industry Position
Table 140. Absolute Antibody CD31 Antibody Models, Specifications and Application
Table 141. Absolute Antibody CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 142. Absolute Antibody Company Profile and Main Business
Table 143. Absolute Antibody Recent Developments
Table 144. EpiGentek Company Information, Head Office, Market Area and Industry Position
Table 145. EpiGentek CD31 Antibody Models, Specifications and Application
Table 146. EpiGentek CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 147. EpiGentek Company Profile and Main Business
Table 148. EpiGentek Recent Developments
Table 149. Biorbyt Company Information, Head Office, Market Area and Industry Position
Table 150. Biorbyt CD31 Antibody Models, Specifications and Application
Table 151. Biorbyt CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 152. Biorbyt Company Profile and Main Business
Table 153. Biorbyt Recent Developments
Table 154. Wuhan Fine Biotech Company Information, Head Office, Market Area and Industry Position
Table 155. Wuhan Fine Biotech CD31 Antibody Models, Specifications and Application
Table 156. Wuhan Fine Biotech CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 157. Wuhan Fine Biotech Company Profile and Main Business
Table 158. Wuhan Fine Biotech Recent Developments
Table 159. Sino Biological Company Information, Head Office, Market Area and Industry Position
Table 160. Sino Biological CD31 Antibody Models, Specifications and Application
Table 161. Sino Biological CD31 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 162. Sino Biological Company Profile and Main Business
Table 163. Sino Biological Recent Developments
List of Figure
Figure 1. CD31 Antibody Picture
Figure 2. By Revenue, Global CD31 Antibody Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global CD31 Antibody Market Size and Forecast, 2018-2029, (L)
Figure 4. Global CD31 Antibody Price Trend, 2018-2029, (US$/L)
Figure 5. By Revenue, China CD31 Antibody Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China CD31 Antibody Market Size and Forecast, 2018-2029, (L)
Figure 7. China CD31 Antibody Price Trend, 2018-2029 (US$/L)
Figure 8. By Revenue, China CD31 Antibody Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China CD31 Antibody Share of Global Market, 2018-2029
Figure 10. Global CD31 Antibody Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global CD31 Antibody Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China CD31 Antibody Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China CD31 Antibody Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China CD31 Antibody Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of CD31 Antibody Domestic VS Export, 2022
Figure 16. Global CD31 Antibody Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global CD31 Antibody Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global CD31 Antibody Production Market Share & Forecast by Region, 2018-2029
Figure 19. CD31 Antibody Industry Chain
Figure 20. CD31 Antibody Procurement Model
Figure 21. CD31 Antibody Sales Model
Figure 22. CD31 Antibody Sales Channels, Direct Sales and Distribution
Figure 23. Monoclonal
Figure 24. Polyclonal
Figure 25. By Type, Global CD31 Antibody Revenue, 2018-2029, US$ Million
Figure 26. By Type, Global CD31 Antibody Revenue Market Share, 2018-2029
Figure 27. By Type, Global CD31 Antibody Sales Volume, 2018-2029, (L)
Figure 28. By Type, Global CD31 Antibody Sales Volume Market Share, 2018-2029
Figure 29. By Type, Global CD31 Antibody Price, 2018-2029, (US$/L)
Figure 30. Immunochemistry (IHC)
Figure 31. Immunofluorescence (IF)
Figure 32. Western Blot (WB)
Figure 33. Immunocytochemistry (ICC)
Figure 34. ELISA
Figure 35. Others
Figure 36. By Application, Global CD31 Antibody Revenue, 2018-2029, US$ Million
Figure 37. By Application, Global CD31 Antibody Revenue Market Share, 2018-2029
Figure 38. By Application, Global CD31 Antibody Sales Volume, 2018-2029, (L)
Figure 39. By Application, Global CD31 Antibody Sales Volume Market Share, 2018-2029
Figure 40. By Application, Global CD31 Antibody Price, 2018-2029, (US$/L)
Figure 41. By Region, Global CD31 Antibody Revenue Market Share, 2018-2029
Figure 42. By Region, Global CD31 Antibody Sales Volume Market Share, 2018-2029
Figure 43. North America CD31 Antibody Revenue & Forecasts, 2018-2029, US$ Million
Figure 44. By Country, North America CD31 Antibody Revenue Market Share, 2022
Figure 45. Europe CD31 Antibody Revenue & Forecasts, 2018-2029, US$ Million
Figure 46. By Country, Europe CD31 Antibody Revenue Market Share, 2022
Figure 47. Asia Pacific CD31 Antibody Revenue & Forecasts, 2018-2029, US$ Million
Figure 48. By Country/Region, Asia Pacific CD31 Antibody Revenue Market Share, 2022
Figure 49. South America CD31 Antibody Revenue & Forecasts, 2018-2029, US$ Million
Figure 50. By Country, South America CD31 Antibody Revenue Market Share, 2022
Figure 51. Middle East & Africa CD31 Antibody Revenue & Forecasts, 2018-2029, US$ Million
Figure 52. U.S. CD31 Antibody Sales Volume, 2018-2029, (L)
Figure 53. By Company, U.S. CD31 Antibody Market Share, 2022
Figure 54. By Type, U.S. CD31 Antibody Sales Volume Market Share, 2022 VS 2029
Figure 55. By Application, U.S. CD31 Antibody Sales Volume Market Share, 2022 VS 2029
Figure 56. Europe CD31 Antibody Sales Volume, 2018-2029, (L)
Figure 57. By Company, Europe CD31 Antibody Market Share, 2022
Figure 58. By Type, Europe CD31 Antibody Sales Volume Market Share, 2022 VS 2029
Figure 59. By Application, Europe CD31 Antibody Sales Volume Market Share, 2022 VS 2029
Figure 60. China CD31 Antibody Sales Volume, 2018-2029, (L)
Figure 61. By Company, China CD31 Antibody Market Share, 2022
Figure 62. By Type, China CD31 Antibody Sales Volume Market Share, 2022 VS 2029
Figure 63. By Application, China CD31 Antibody Sales Volume Market Share, 2022 VS 2029
Figure 64. Japan CD31 Antibody Sales Volume, 2018-2029, (L)
Figure 65. By Company, Japan CD31 Antibody Market Share, 2022
Figure 66. By Type, Japan CD31 Antibody Sales Volume Market Share, 2022 VS 2029
Figure 67. By Application, Japan CD31 Antibody Sales Volume Market Share, 2022 VS 2029
Figure 68. South Korea CD31 Antibody Sales Volume, 2018-2029, (L)
Figure 69. By Company, South Korea CD31 Antibody Market Share, 2022
Figure 70. By Type, South Korea CD31 Antibody Sales Volume Market Share, 2022 VS 2029
Figure 71. By Application, South Korea CD31 Antibody Sales Volume Market Share, 2022 VS 2029
Figure 72. Southeast Asia CD31 Antibody Sales Volume, 2018-2029, (L)
Figure 73. By Company, Southeast Asia CD31 Antibody Market Share, 2022
Figure 74. By Type, Southeast Asia CD31 Antibody Sales Volume Market Share, 2022 VS 2029
Figure 75. By Application, Southeast Asia CD31 Antibody Sales Volume Market Share, 2022 VS 2029
Figure 76. India CD31 Antibody Sales Volume, 2018-2029, (L)
Figure 77. By Company, India CD31 Antibody Market Share, 2022
Figure 78. By Type, India CD31 Antibody Sales Volume Market Share, 2022 VS 2029
Figure 79. By Application, India CD31 Antibody Sales Volume Market Share, 2022 VS 2029
Figure 80. Middle East & Asia CD31 Antibody Sales Volume, 2018-2029, (L)
Figure 81. By Company, Middle East & Asia CD31 Antibody Market Share, 2022
Figure 82. By Type, Middle East & Asia CD31 Antibody Sales Volume Market Share, 2022 VS 2029
Figure 83. By Application, Middle East & Asia CD31 Antibody Sales Volume Market Share, 2022 VS 2029
Figure 84. Research Methodology
Figure 85. Breakdown of Primary Interviews
Figure 86. Bottom-up Approaches
Figure 87. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|